Statute Details
- Title: Medicines (Veterinary Medicinal Products) (Exemption) Order
- Act Code: MA1975-OR1
- Legislative Type: Subsidiary legislation (Order)
- Authorising Act: Medicines Act (Chapter 176), Section 9
- Commencement Date: Not stated in the provided extract (the Order is shown with a commencement/annotation date of 24th June 1977 in the citation block)
- Current Version: Current version as at 27 Mar 2026 (per the platform status)
- Key Provisions: Section 1 (Citation); Section 2 (Exemption)
- Primary Legal Effect: Exempts veterinary medicinal products from the prohibition in Section 6 of the Medicines Act (prohibition against manufacture and wholesale dealing of a medicinal product)
- Regulatory Instrument Reference: G.N. No. S 143/77 (as shown in the extract)
What Is This Legislation About?
The Medicines (Veterinary Medicinal Products) (Exemption) Order is a short but legally significant instrument within Singapore’s medicines regulatory framework. In substance, it creates a targeted exemption for veterinary medicinal products from a specific statutory prohibition contained in the Medicines Act.
Under the Medicines Act, certain activities involving medicinal products—particularly manufacture and wholesale dealing—are restricted. The policy rationale is typically to ensure that medicinal products are properly regulated, safe, and subject to licensing or other controls. However, the regulatory landscape may treat veterinary medicines differently from human medicines due to differences in distribution channels, end-users (animals rather than humans), and practical realities in veterinary practice and animal agriculture.
This Order addresses that regulatory boundary by stating that Section 6 of the Medicines Act does not apply to veterinary medicinal products. In plain terms: the Act’s prohibition on manufacture and wholesale dealing of a medicinal product is not triggered (at least as far as Section 6 is concerned) when the medicinal product is classified as a veterinary medicinal product.
What Are the Key Provisions?
Section 1 (Citation) is a standard provision. It allows the instrument to be referred to by its short title: the “Medicines (Veterinary Medicinal Products) (Exemption) Order.” While not substantive, citation provisions matter for legal drafting, compliance documentation, and for identifying the correct instrument in regulatory correspondence or enforcement proceedings.
Section 2 (Exemption) is the operative clause. It provides that: “Section 6 of the Act (prohibition against manufacture and wholesale dealing of medicinal product) shall not apply to veterinary medicinal products.” This is the entire substantive content of the Order as reflected in the extract.
From a practitioner’s perspective, the legal effect of Section 2 turns on two interpretive questions: (1) what exactly counts as a “medicinal product” under the Medicines Act, and (2) what qualifies as a “veterinary medicinal product.” The Order itself does not define those terms in the extract, so lawyers typically need to consult the Medicines Act definitions and any related subsidiary legislation or guidance that clarifies classification.
Assuming the product falls within the statutory definition of a veterinary medicinal product, the exemption operates to remove the applicability of Section 6. That means that the specific prohibition on manufacture and wholesale dealing—as set out in Section 6—cannot be relied upon to stop those activities for veterinary medicines. However, the exemption is not necessarily a blanket permission for all regulatory requirements. It only states that Section 6 “shall not apply.” Other provisions of the Medicines Act (for example, licensing requirements, quality control, importation rules, labelling requirements, or offences relating to unsafe or unregistered products) may still apply depending on their wording and scope.
Accordingly, the Order should be read as a narrow statutory carve-out rather than a general deregulation measure. The exemption is specific: it targets the prohibition in Section 6 and does not, on its face, remove other obligations that may attach to veterinary medicinal products under the broader statutory scheme.
How Is This Legislation Structured?
The instrument is structured as a very brief Order with two sections:
Section 1 sets out the citation (short title). Section 2 provides the exemption. There are no additional parts, schedules, or detailed conditions in the extract. This kind of structure is typical for subsidiary legislation that performs a discrete legal function—here, carving out an exemption from a particular prohibition.
Because the Order is short, its practical meaning depends heavily on the interplay with the Medicines Act. In legal analysis, the Order is best treated as a “switch” that changes the applicability of Section 6 for veterinary medicinal products, while leaving the rest of the Medicines Act intact unless expressly amended or exempted elsewhere.
Who Does This Legislation Apply To?
The exemption is directed at the regulatory treatment of veterinary medicinal products. In practice, it affects persons and businesses engaged in activities that would otherwise fall within the scope of Section 6—particularly those involved in the manufacture and wholesale dealing of veterinary medicines.
Potential affected stakeholders include veterinary pharmaceutical manufacturers, wholesalers/distributors, and importers who operate in the veterinary supply chain. However, the exemption’s legal reach is tied to the product category, not directly to the business type. Therefore, a lawyer advising a company must first confirm whether the product is properly characterised as a veterinary medicinal product under the Medicines Act framework.
Even where Section 6 is exempted, businesses should not assume that all regulatory controls are removed. The exemption only states that Section 6 “shall not apply.” Other provisions of the Medicines Act and any applicable subsidiary legislation may still impose licensing, registration, quality, safety, record-keeping, labelling, or enforcement-related requirements. A careful compliance review should therefore consider the entire statutory scheme, not only Section 6.
Why Is This Legislation Important?
Although the Order is brief, it can have meaningful commercial and compliance consequences. Section 6 of the Medicines Act is described in the extract as a prohibition against manufacture and wholesale dealing of medicinal product. Prohibitions of that kind typically create a high compliance barrier: without an exemption or licence, regulated activities may be unlawful and expose businesses to enforcement action.
By exempting veterinary medicinal products from Section 6, the Order reduces the risk that manufacturers and wholesalers of veterinary medicines will be treated as committing an offence (or breaching a prohibition) solely by virtue of engaging in manufacture and wholesale dealing. This can be crucial for the veterinary sector, where timely access to medicines is important for animal health and welfare, and where distribution networks may differ from human healthcare supply chains.
From an enforcement and litigation standpoint, the Order also provides a clear statutory defence or limitation on the applicability of Section 6. If an enforcement authority attempts to rely on Section 6 to regulate manufacture or wholesale dealing of a product claimed to be veterinary, the existence of this exemption becomes central. Practitioners should therefore ensure that evidence and documentation support the classification of the product as a veterinary medicinal product—such as intended use, labelling, regulatory registration status, and how the product is marketed and supplied.
Finally, the Order illustrates a broader regulatory technique used in Singapore legislation: rather than rewriting the Medicines Act, the legislature uses subsidiary legislation to adjust how particular statutory provisions apply to defined categories of products. This approach supports targeted policy outcomes while preserving the structure of the main Act.
Related Legislation
- Medicines Act (Chapter 176), including:
- Section 6 (prohibition against manufacture and wholesale dealing of a medicinal product) — exempted for veterinary medicinal products by this Order
- Section 9 (authorising provision for the making of the Order)
Source Documents
This article provides an overview of the Medicines (Veterinary Medicinal Products) (Exemption) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.